HCM
CME icon

Highview Capital Management’s CME Group CME Stock Holding History

Highview Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.96M Buy
6,642
+5,480
+472% +$1.63M 0.71% 36
2025
Q4 		$317K Buy
1,162
+12
+1% +$3.26K 0.11% 91
2025
Q3 		$311K Hold
1,150
– – 0.11% 90
2025
Q2 		$317K Hold
1,150
– – 0.12% 93
2025
Q1 		$305K Hold
1,150
– – 0.13% 89
2024
Q4 		$267K Hold
1,150
– – 0.1% 112
2024
Q3 		$254K Sell
1,150
-150
-12% -$31K 0.1% 107
2024
Q2 		$256K Sell
1,300
-7,772
-86% -$1.61M 0.11% 107
2024
Q1 		$1.95M Buy
9,072
+279
+3% +$58.6K 0.88% 30
2023
Q4 		$1.85M Buy
8,793
+630
+8% +$134K 0.99% 30
2023
Q3 		$1.63M Sell
8,163
-152
-2% -$30.2K 0.93% 29
2023
Q2 		$1.54M Buy
8,315
+90
+1% +$16.6K 0.83% 34
2023
Q1 		$1.58M Buy
8,225
+4,333
+111% +$784K 0.91% 28
2022
Q4 		$654K Sell
3,892
-3,111
-44% -$541K 0.4% 65
2022
Q3 		$1.24M Buy
7,003
+186
+3% +$36.8K 0.92% 29
2022
Q2 		$1.4M Buy
6,817
+1,519
+29% +$322K 1.07% 25
2022
Q1 		$1.26M Buy
5,298
+4,198
+382% +$986K 0.81% 33
2021
Q4 		$251K Buy
+1,100
New +$242K 0.16% 96

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Highview Capital Management's CME Position: Q1 2026 in Review

Highview Capital Management increased its CME Group (CME) stake by 472% in Q1 2026, buying an estimated $1.63M and bringing the position to 6,642 shares worth $1.96M. The position accounts for 0.71% of the portfolio, ranked #36.

Highview Capital Management first reported a position in CME in Q4 2021 and has held it in 18 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Highview Capital Management held 6,642 shares of CME Group worth $1.96M as of Q1 2026.
  • Highview Capital Management bought 5,480 CME Group shares in Q1 2026, an estimated $1.63M.
  • CME Group made up 0.71% of Highview Capital Management's portfolio in Q1 2026, its #36 holding.
  • Highview Capital Management first reported a position in CME Group in Q4 2021 and has held it in 18 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Highview Capital Management's 13F filing for Q1 2026, filed 8 May 2026.